Ethyl 7-bromoimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 1g

Copper(I) bromide, min. 99%, 5 mg, plastic packaging.

6-Cyclobutoxypyridine-2,3-diamine hydrochloride, 100mg

N-(Butoxymethyl)acrylamide (stabilized with MEHQ)>96.0%(T)500mL

tert-Butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate, 95.0%, 100mg

2-(7-Methoxy-2-oxo-2H-chromen-4-yl)acetic acid, 95.0%, 100g

4,6-dichloro-5-ethyl-2-methylpyrimidine, 95.0%, 500mg

4-Ethynylaniline, 95.0%, 100g

(4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol, 95.0%, 100mg

2-Chloro-11-methyl-5H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6(11H)-one, 95%, 250mg

4-Chlorophenylhydrazine Sulfate>95.0%(T)500g

6-Bromopyridazine-3-carbaldehyde, 98%, 100mg

5-Amino-isoindole-1,3-dione, 95.0%, 25g